Proscia, Philadelphia, has introduced the third generation of its Concentriq platform. This release includes features and enhancements that centralize pathology operations across an enterprise, bringing together multi-site teams, data, and third-party applications. Life sciences organizations have been at the forefront of digital pathology adoption, generating millions of images and increasingly complex data at the heart of their research. Despite the value that this information can provide, it often remains siloed in outdated software systems where it is difficult for teams to manage, analyze, and share, hampering R&D progress and limiting scientific potential. Proscia introduced the Concentriq image and data management platform to help life sciences organizations overcome these challenges and scale digital pathology adoption across the enterprise. The third generation of Concentriq, which is now available, delivers new features and enhancements to further unify pathology operations in a single platform, integrating multiple applications, improving collaboration, and supporting remote teams. Concentriq now offers new and improved capabilities across the platform to provide:
- Enhanced enterprise scalability and security – Front-end and back-end improvements, including expanded user management, automation, and storage optimization, support the platform in delivering the scalability required to securely extend digital pathology adoption across additional stakeholders and growing volumes of data.
- A new dedicated workspace for multi-site teams – Concentriq’s increasingly robust feature set supports the end-to-end workflow for internal and external stakeholders. From optimized image viewing to streamlined sharing and best-in-class interoperability, Concentriq now further enables single and multi-site teams to conduct their research entirely within the platform, driving efficiency in day-to-day work and strengthening collaboration.
- Expanded data analysis capabilities – The third generation of Concentriq makes it even easier for teams to intuitively manage and access their data. With this increased visibility, researchers can identify impactful trends and patterns in just a few clicks, unlocking new data-driven insights to accelerate discovery.
“Life sciences organizations have collected massive volumes of pathology data, which could lead to the next major breakthroughs,” says Nathan Buchbinder, Proscia’s chief product officer. “We’ve expanded Concentriq’s feature set to give researchers sophisticated capabilities for capitalizing on the value of this information. From streamlining operations to improving collaboration, Concentriq is enabling organizations to practice digital pathology at scale in the quest to unlock new insights.” Concentriq is the digital pathology platform used by leading organizations to transform image-based research across the enterprise. The software can be rapidly deployed on existing IT infrastructure and works with leading scanners, laboratory information systems (LIS), and image analysis applications, offering seamless integration with Philips, Leica, Hamamatsu, and Visiopharm among other solutions. “Concentriq has been critical in keeping our science moving forward,” says Emily Singletary, digital imaging unit supervisor, EPL Inc. “The platform has transformed how we manage our pathology research and is now enabling our clients’ teams to operate remotely without interruption. By further centralizing our pathology operations, this new release will help us to take an increasingly data-driven approach to pathology and accelerate discovery.” For more information, visit Proscia.